Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.

Kolesar JM, Pomplun M, Havighurst T, Stublaski J, Wollmer B, Kim K, Tangrea JA, Parnes HL, House MG, Gee J, Messing E, Bailey HH.

J Oncol Pharm Pract. 2015 Apr;21(2):128-31. doi: 10.1177/1078155214528552. Epub 2014 Mar 17.

2.

A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.

Linden KG, Leachman SA, Zager JS, Jakowatz JG, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea JA, Lim SJ, Cochran AJ, Meyskens FL Jr.

Cancer Prev Res (Phila). 2014 May;7(5):496-504. doi: 10.1158/1940-6207.CAPR-13-0189. Epub 2014 Mar 10.

3.

Prostate cancer prevention: agent development strategies.

Parnes HL, House MG, Tangrea JA.

Recent Results Cancer Res. 2014;202:121-31. doi: 10.1007/978-3-642-45195-9_15.

PMID:
24531786
4.

Prostate cancer prevention: strategies for agent development.

Parnes HL, House MG, Tangrea JA.

Curr Opin Oncol. 2013 May;25(3):242-51. doi: 10.1097/CCO.0b013e32835fc8d4. Review.

PMID:
23518594
5.

Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.

Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL, Sokoloff MH, Gretzer MB, Chow HH.

Cancer Prev Res (Phila). 2012 Feb;5(2):290-8. doi: 10.1158/1940-6207.CAPR-11-0306. Epub 2011 Nov 1.

6.

Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland.

Kidd LR, Hein DW, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA.

Biochem Genet. 2011 Feb;49(1-2):73-82. doi: 10.1007/s10528-010-9386-4. Epub 2010 Oct 8.

7.

Epidemiological and clinical studies of nutrition.

Gibson TM, Ferrucci LM, Tangrea JA, Schatzkin A.

Semin Oncol. 2010 Jun;37(3):282-96. doi: 10.1053/j.seminoncol.2010.05.011. Review.

8.

Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland.

Brock KE, Graubard BI, Fraser DR, Weinstein SJ, Stolzenberg-Solomon RZ, Lim U, Tangrea JA, Virtamo J, Ke L, Snyder K, Albanes D.

Eur J Clin Nutr. 2010 Mar;64(3):280-8. doi: 10.1038/ejcn.2009.137. Epub 2010 Jan 6.

9.

Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.

Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2784-6. No abstract available.

10.

The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.

Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.

J Urol. 2008 Feb;179(2):508-11; discussion 511-2.

PMID:
18076912
11.

Association of IL-10 polymorphisms with prostate cancer risk and grade of disease.

Faupel-Badger JM, Kidd LC, Albanes D, Virtamo J, Woodson K, Tangrea JA.

Cancer Causes Control. 2008 Mar;19(2):119-24. Epub 2007 Nov 13.

PMID:
17999153
12.

CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease.

Woodson K, O'Reilly KJ, Ward DE, Walter J, Hanson J, Walk EL, Tangrea JA.

Epigenetics. 2006 Oct-Dec;1(4):183-6. Epub 2006 Oct 24.

PMID:
17998819
13.

Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial.

Yang HP, Woodson K, Taylor PR, Pietinen P, Albanes D, Virtamo J, Tangrea JA.

Eur J Cancer Prev. 2006 Jun;15(3):249-53.

PMID:
16679868
14.

Gene promoter methylation in prostate tumor-associated stromal cells.

Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.

J Natl Cancer Inst. 2006 Feb 15;98(4):255-61.

PMID:
16478744
15.

Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Diaw L, Roth M, Schwinn DA, d'Alelio ME, Green LJ, Tangrea JA.

In Vitro Cell Dev Biol Anim. 2005 May-Jun;41(5-6):142-8.

PMID:
16153146
16.

Aspirin use and mortality from cancer in a prospective cohort study.

Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E.

Anticancer Res. 2004 Sep-Oct;24(5B):3177-84.

17.

Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer.

Dorgan JF, Boakye NA, Fears TR, Schleicher RL, Helsel W, Anderson C, Robinson J, Guin JD, Lessin S, Ratnasinghe LD, Tangrea JA.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1276-82.

18.

Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens.

Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA.

Prostate. 2004 Jun 15;60(1):25-31.

PMID:
15129426
19.

Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women.

Woodson K, Flood A, Green L, Tangrea JA, Hanson J, Cash B, Schatzkin A, Schoenfeld P.

J Natl Cancer Inst. 2004 Mar 3;96(5):407-10.

PMID:
14996863
20.

Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).

Woodson K, Tangrea JA, Lehman TA, Modali R, Taylor KM, Snyder K, Taylor PR, Virtamo J, Albanes D.

Cancer Causes Control. 2003 Aug;14(6):513-8.

PMID:
12948282
21.

Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).

Tangrea JA, Albert PS, Lanza E, Woodson K, Corle D, Hasson M, Burt R, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A; Polyp Prevention Study Group.

Cancer Causes Control. 2003 Jun;14(5):403-11.

PMID:
12946034
22.
23.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

24.

Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland.

Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR, Albanes D.

Cancer Lett. 2003 Mar 10;191(2):171-8.

PMID:
12618330
25.

Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States).

Colbert LH, Lanza E, Ballard-Barbash R, Slattery ML, Tangrea JA, Caan B, Paskett ED, Iber F, Kikendall W, Lance P, Shike M, Schoen RE, Daston C, Schatzkin A; Polyp Prevention Trial Study Group.

Cancer Causes Control. 2002 Jun;13(5):445-53.

PMID:
12146849
26.

Physical activity and lung cancer risk in male smokers.

Colbert LH, Hartman TJ, Tangrea JA, Pietinen P, Virtamo J, Taylor PR, Albanes D.

Int J Cancer. 2002 Apr 10;98(5):770-3.

27.

Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial.

Woodson K, Lanza E, Tangrea JA, Albert PS, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A.

J Natl Cancer Inst. 2001 Dec 5;93(23):1799-805.

PMID:
11734596
28.

Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?

Ratnasinghe D, Daschner PJ, Anver MR, Kasprzak BH, Taylor PR, Yeh GC, Tangrea JA.

Anticancer Res. 2001 May-Jun;21(3C):2141-7.

PMID:
11501838
29.

Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking--lung cancer association.

Ratnasinghe D, Tangrea JA, Stewart C, Bhat NK, Virtamo J, Albanes D, Taylor PR.

Anticancer Res. 2001 Mar-Apr;21(2B):1295-9.

PMID:
11396202
30.

Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk.

Ratnasinghe D, Yao SX, Tangrea JA, Qiao YL, Andersen MR, Barrett MJ, Giffen CA, Erozan Y, Tockman MS, Taylor PR.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):119-23.

31.

Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland.

Misra RR, Tangrea JA, Virtamo J, Ratnasinghe D, Andersen MR, Barrett M, Taylor PR, Albanes D.

Cancer Lett. 2001 Mar 26;164(2):161-7.

PMID:
11179831
32.

Effects of long-term alpha-tocopherol supplementation on serum hormones in older men.

Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, Taylor PR, Barrett MJ, Albanes D.

Prostate. 2001 Jan 1;46(1):33-8.

PMID:
11170129
33.

Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk.

Ratnasinghe D, Tangrea JA, Andersen MR, Barrett MJ, Virtamo J, Taylor PR, Albanes D.

Cancer Res. 2000 Nov 15;60(22):6381-3.

34.

Serum carotenoids are associated with increased lung cancer risk among alcohol drinkers, but not among non-drinkers in a cohort of tin miners.

Ratnasinghe D, Forman MR, Tangrea JA, Qiao Y, Yao SX, Gunter EW, Barrett MJ, Giffen CA, Erozan Y, Tockman MS, Taylor PR.

Alcohol Alcohol. 2000 Jul-Aug;35(4):355-60.

PMID:
10906000
35.

Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China.

Roth MJ, Dawsey SM, Wang G, Tangrea JA, Zhou B, Ratnasinghe D, Woodson KG, Olivero OA, Poirier MC, Frye BL, Taylor PR, Weston A.

Cancer Lett. 2000 Aug 1;156(1):73-81.

PMID:
10840162
36.

Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland)

Albanes D, Malila N, Taylor PR, Huttunen JK, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Barrett MJ, Pietinen P, Hartman TJ, Sipponen P, Lewin K, Teerenhovi L, Hietanen P, Tangrea JA, Virtanen M, Heinonen OP.

Cancer Causes Control. 2000 Mar;11(3):197-205.

PMID:
10782653
37.

Serum tocopherols, selenium and lung cancer risk among tin miners in China.

Ratnasinghe D, Tangrea JA, Forman MR, Hartman T, Gunter EW, Qiao YL, Yao SX, Barett MJ, Giffen CA, Erozan Y, Tockman MS, Taylor PR.

Cancer Causes Control. 2000 Feb;11(2):129-35.

PMID:
10710196
38.

Association between serum alpha-tocopherol and serum androgens and estrogens in older men.

Hartman TJ, Dorgan JF, Virtamo J, Tangrea JA, Taylor PR, Albanes D.

Nutr Cancer. 1999;35(1):10-5.

PMID:
10624701
39.

The effect of beta-carotene supplementation on serum vitamin D metabolite concentrations.

Freedman DM, Tangrea JA, Virtamo J, Albanes D.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1115-6.

40.

Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial.

Woodson K, Ratnasinghe D, Bhat NK, Stewart C, Tangrea JA, Hartman TJ, Stolzenberg-Solomon R, Virtamo J, Taylor PR, Albanes D.

Eur J Cancer Prev. 1999 Oct;8(5):441-7.

PMID:
10548400
41.

Diet and risk of colorectal cancer in a cohort of Finnish men.

Pietinen P, Malila N, Virtanen M, Hartman TJ, Tangrea JA, Albanes D, Virtamo J.

Cancer Causes Control. 1999 Oct;10(5):387-96.

PMID:
10530608
42.

Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers.

Woodson K, Tangrea JA, Barrett MJ, Virtamo J, Taylor PR, Albanes D.

J Natl Cancer Inst. 1999 Oct 20;91(20):1738-43.

PMID:
10528024
43.

Association between alcohol and lung cancer in the alpha-tocopherol, beta-carotene cancer prevention study in Finland.

Woodson K, Albanes D, Tangrea JA, Rautalahti M, Virtamo J, Taylor PR.

Cancer Causes Control. 1999 Jun;10(3):219-26.

PMID:
10454067
44.

Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus.

Ratnasinghe D, Tangrea JA, Roth MJ, Dawsey SM, Anver M, Kasprzak BA, Hu N, Wang QH, Taylor PR.

Oncol Rep. 1999 Sep-Oct;6(5):965-8.

PMID:
10425287
45.

The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers.

Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK.

Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):489-93.

46.

Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers.

Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR.

J Natl Cancer Inst. 1999 Mar 17;91(6):535-41.

PMID:
10088624
47.

Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men.

Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M, Taylor PR, Albanes D.

Nutr Cancer. 1998;31(1):41-8.

PMID:
9682247
48.

The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.

Hartman TJ, Albanes D, Pietinen P, Hartman AM, Rautalahti M, Tangrea JA, Taylor PR.

Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):335-40.

49.

Physical activity and prostate cancer in the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study (Finland).

Hartman TJ, Albanes D, Rautalahti M, Tangrea JA, Virtamo J, Stolzenberg R, Taylor PR.

Cancer Causes Control. 1998 Jan;9(1):11-8.

PMID:
9486459
50.

Patient participation and compliance in cancer chemoprevention trials: issues and concerns.

Tangrea JA.

Proc Soc Exp Biol Med. 1997 Nov;216(2):260-5. Review.

PMID:
9349695

Supplemental Content

Loading ...
Support Center